Skip to content

Improvement effect of substance X on human bowel movement.

Improvement effect of substance X on human bowel movement. - Improvement effect of substance X on human bowel movement.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024112
Enrollment
40
Registered
2016-09-20
Start date
2016-09-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendency for constipation

Interventions

Test beverage A (contaning low-dose X) for 2-week intake -&gt
Placebo beverage (control) for 2-week intake Placebo beverage (control) for 2-week intake -&gt
Test beverage A for 2-week intake Test beverage B (contaning high-dose X) for 2-week intake -&gt
Test beverage B for 2-week intake

Sponsors

Medical Corporation Hokubukai, Utsukushigaoka Hospital
Lead Sponsor
Clinical Support Corporation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy Japanese Subjects. 2)Subjects with tendency for constipation (at 4 times or less of defecation per week). 3)Subjects who take regular meals.

Exclusion criteria

Exclusion criteria: 1)Subjects with medical history of severe disorders. 2)Subjects with continuous medical treatment. 3)Subjects with surgical history of digestive system (except appendectomy). 4)Subjects who take any kind of medicine (intestinal, laxative medicine etc) regularly that possibly affect bowel movement. 5) Subjects who take supplements and/or functional foods (including Food for Specified Health Uses [FOSHU] regularly that possibly affect bowel movement. 6)Pregnant or have possibility to become pregnant during the study or lactating women. 7)Subjects who drink alcohol a lot regularly. 8)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

Design outcomes

Primary

MeasureTime frame
Defecation days, defecation frequency

Secondary

MeasureTime frame
1)Amount of feces, fecal condition (form, color, smell, feeling after defecation) 2)Change of subjective symptoms of intolerance to cold

Countries

Japan

Contacts

Public ContactYuki Ishida

Hayashibara CO., LTD. R & D Division, Development Unit

yuki.ishida@hb.nagase.co.jp086-276-3141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026